In Nigeria, a country of 242 million people, there are approximately 80 oncologists. There are roughly 27,500 in the United States, for a population not even halfway as large. And according to the World Health Organization, cancer cases in sub-Saharan Africa are on track to more than double by 2050, faster than anywhere else on earth.
She Had to Find Her Own Chemotherapy Drugs
Titilayo, a woman living in southern Nigeria, found a lump in her left breast. What followed was not a swift referral to an oncology team and a treatment plan. It was weeks of waiting for a biopsy sample to travel to Abuja, Nigeria's capital, just to find out whether the lump was cancerous. It was.
Her doctor recommended a mastectomy and multiple rounds of chemotherapy. The chemotherapy infusions, as NPR reports, were not reliably available where she lived. So the burden of actually obtaining them fell entirely on her. She had to source the drugs in another state and physically bring them to the hospital herself.
"The burden of getting the chemotherapy drugs," she told NPR, "the burden was on me." She kept going anyway, because she has three young daughters. "If I die of this thing," she said, "who would be able to care for my children?"
The Numbers Are Staggering and Getting Worse
The WHO projects that by 2050, cancer cases across sub-Saharan Africa will more than double. That is the highest predicted rate of increase of any of the WHO's six designated global regions. The Eastern Mediterranean, covering much of northern Africa and the Gulf states, is a close second.
One in five people alive today will be diagnosed with cancer at some point in their lifetime. In wealthy countries, that statistic increasingly comes with improving odds. Treatments are getting better. Survival rates are climbing. In the countries where cancer is growing fastest, that progress is largely not arriving.
Dr. Basira Hanafi Lawal, a radiation oncologist in Abuja, told NPR she's watching this unfold in real time. "We're wondering, are we creating more awareness for people and that's why they're coming in, or are the numbers just increasing?" she said. The honest answer, based on the data, is both.
Late Diagnoses and an Impossible Workload
Dr. Lawal estimates that roughly 70% of her patients arrive at stage 3 or stage 4, meaning the cancer has already spread from its original site into surrounding tissue, lymph nodes, or other organs. That is the stage where options narrow fast and outcomes get brutal.
The reasons for late-stage diagnosis are not mysterious. There are not enough doctors, not enough screening centers, and not enough money. Nigeria has only 15 radiation therapy centers for the entire country. Some of Lawal's patients travel eight hours to reach her. And even when patients detect something early, as breast cancer survivor and advocate Abigail Simon-Hart told NPR, the next steps are not obvious. "Sometimes they've detected it earlier and they don't know where to go," she said. "Sometimes they know where to go but they don't have the money."
The brain drain compounds everything. Nigeria trains doctors, and then those doctors take jobs in countries where the healthcare system is not held together with duct tape and willpower. That is not a criticism of the doctors. It is an indictment of the conditions they are being asked to work in.
Patients Are Paying for Almost All of It Themselves
In 2022, according to data from the WHO's Global Health Expenditure Database, patients in Nigeria were responsible for more than 80% of cancer care costs. That is not a typo. More than 80 cents of every dollar spent on cancer care in Nigeria came out of the pockets of the patients themselves, or their families.
Many Nigerian health insurance plans, NPR reports, simply do not cover comprehensive cancer care. What this looks like in practice: crowdfunding posts on local websites, patients selling their assets, families taking out bank loans, begging friends and relatives for money, and still sometimes losing the person they were trying to save.
"I've seen people sell everything they have and still lose their loved ones," Simon-Hart said. Regina Fisayo Akinola, a breast cancer survivor who finished treatment in 2014 and then faced a second tumor in her right breast in 2020, described the same grinding financial reality. "We have to go through loans," she told NPR, "bank loans, to take loans from our workplace or to solicit funds from friends and family."
A Crisis Without Easy Exits
The risk factors driving rising cancer rates in Nigeria are, unfortunately, familiar ones. As NPR reports, Dr. Lawal points to a growing older population, rising rates of alcohol and tobacco use, and increasingly urban and sedentary lifestyles. These are the same factors that drove the cancer surge in wealthy countries decades ago, except wealthy countries had functioning healthcare infrastructure in place when it arrived.
There are some bright spots worth naming. Screening and awareness campaigns run by nonprofits and religious groups are getting some patients in the door earlier. Lawal says she is seeing people come in at early stages who might not have come in at all a generation ago. That matters. Early detection saves lives, when the treatment is available.
But the structural gaps are not the kind of thing a good awareness campaign can fix. Fifteen radiation centers for 242 million people is not a messaging problem. Eighty oncologists for a population that size is not something you solve with a fundraising drive.
The Dingo Take
Here is the part where we are supposed to say something hopeful about the global community stepping up. We are not going to do that, because the global community has had decades to step up on healthcare equity and keeps not doing it in any serious way. The WHO can publish projections all it wants. Until the money and the political will follow, those projections are just a detailed description of preventable deaths.
What makes this story so maddening is how avoidable the worst of it is. Cancer treatment works. We know how to do this. We have the drugs, the knowledge, the technology. What we do not have, apparently, is any collective interest in making sure those things exist in the places that need them most. Titilayo had to travel across state lines carrying her own chemotherapy. That is not a healthcare system. That is an obstacle course with a cancer diagnosis at the start.
And before anyone gets comfortable thinking this is purely a foreign policy abstraction, remember that the United States has been systematically gutting its global health commitments. The budgets that fund international health programs, including the kind of infrastructure that helps countries like Nigeria build oncology capacity, have been on the chopping block for years. We are not innocent bystanders watching a crisis from a distance. We are actively making choices that determine whether Titilayo's daughters grow up with a mother.
